晚期非小细胞肺癌一线和维持治疗的选择研究报告.ppt

IHC, immunohistochemistry. * IDST, interactive decision support tool. * Carbo, carboplatinum; cis, cisplatinum; CT, chemotherapy; doc, docetaxel; EGFR, epidermal growth factor receptor; gem, gemcitabine; OS, overall survival; pem, pemetrexed; PFS, progression-free survival; plt, platinum; TKI, tyrosine kinase inhibitor. * EGFR, epidermal growth factor receptor; PFS, progression-free survival; TKI, tyrosine kinase inhibitor. * ALK, anaplastic lymphoma kinase; NR, not reported; NSCLC, non-small-cell lung cancer; PFS, progression-free survival. * ALK, anaplastic lymphoma kinase; EGFR, epide